Search
From Date :
To Date :
Serivce :
Query :
Keywords :
 ( Seprate With , )
Novartis heart drug fails trial
Novartis’s heart failure drug Entresto failed a trial in a new use, the Swiss drugmaker said on Monday, calling into question billions of dollars in potential revenue and taking the shine off one of the company’s biggest growth prospects.
US group: Novartis gene therapy would be cost effective up to $900,000
An experimental gene therapy for spinal muscular atrophy (SMA) developed by Novartis AG would be worth up to $900,000, according to an independent US nonprofit organization that reviews the value of drugs and medical treatments.
Novartis to cut 2,200 jobs in Switzerland to boost profitability
Drugmaker Novartis (NOVN.S) will cut about 2,200 jobs in Switzerland over the next four years as it consolidates production and shifts positions elsewhere to boost profitability, the Swiss company said on Tuesday.

Page Generated in 0/4999 sec